Symposia: Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Acute Myeloid Malignancies, AML, MDS, Combination therapy, Apoptosis, Adult, Fundamental Science, Translational Research, Drug development, Elderly, CHIP, Clinical Research, Chemotherapy, Genomics, Drug-drug interactions, Chronic Myeloid Malignancies, Education, Diseases, Immune mechanism, Treatment Considerations, Immunology, Non-Biological therapies, Metabolism, Myeloid Malignancies, Pharmacology, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Pathogenesis, Animal model, Measurable Residual Disease , Molecular testing, Omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Acute Myeloid Malignancies, AML, MDS, Combination therapy, Apoptosis, Adult, Fundamental Science, Translational Research, Drug development, Elderly, CHIP, Clinical Research, Chemotherapy, Genomics, Drug-drug interactions, Chronic Myeloid Malignancies, Education, Diseases, Immune mechanism, Treatment Considerations, Immunology, Non-Biological therapies, Metabolism, Myeloid Malignancies, Pharmacology, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Pathogenesis, Animal model, Measurable Residual Disease , Molecular testing, Omics technologies
Saturday, December 7, 2024: 9:30 AM-11:00 AM
Grand Hall B
(Manchester Grand Hyatt San Diego)
Moderators:
Saravanan Ganesan, PhD,
and
Shruti Bhatt, PhD,
Disclosures:
No relevant conflicts of interest to declare.
9:45 AM
10:00 AM
10:15 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH